Due to the lack of biological information on these compounds, our group has docked them against 7 proteins which have cannabinoid like ligands to identify key ligand interactions, while also compiling ADMET information, and hypothesized p450 sites of metabolism. The contribution of providing in-silico information provides context in discerning possible interaction within selected proteins and contrasting with other cannabinoids to determine agonistic, or antagonistic effects on selected proteins to help design biological studies and design analogs to treat diseases and ailments .